Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
2015 Nobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu 5 ) X-ray Structures
2018
New clinical trials for nonmotor manifestations of Parkinson's disease
2015
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
2012
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
2019
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Parkinson's disease
2021 Standout
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
2008
Parkinson's disease: clinical features and diagnosis
2008 Standout
The pathophysiological basis of sensory disturbances in Parkinson's disease
2009
Tissue-resident macrophages
2013 Standout
Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life
2009
Parkinson's disease
2009 Standout
Priorities in Parkinson's disease research
2011
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Tau in physiology and pathology
2015 Standout
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management
2016
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Weight loss by mobile phone: a 1-year effectiveness study
2009
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Parkinson's disease in the Western Pacific Region
2019
Microglial activation in presymptomatic Huntington's disease gene carriers
2007
Parkinson's disease
2015 Standout
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
2009 Standout
Tracking and Elucidating Alphavirus-Host Protein Interactions
2006 StandoutNobel
CD200–CD200R Regulation of Microglia Activation in the Pathogenesis of Parkinson’s Disease
2007
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
2013 Standout
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
2011
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration
2006
Using Internet Technology to Deliver a Behavioral Weight Loss Program
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
2008
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Non-motor features of Parkinson disease
2017 Standout
Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics
2017
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
2011
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
2020
Imaging biomarkers in Parkinson's disease
2011
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
2008
Effects of 6‐hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line‐derived neurotrophic factor
2004
Deep-Brain Stimulation for Parkinson's Disease
2012
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
2016 Standout
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
2009
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Colonic inflammation in Parkinson's disease
2012
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
2011
Pathological correlates of gastrointestinal dysfunction in Parkinson's disease
2011
Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies
2013
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
2008
Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
2007
Mitochondrial Complex 1 Inhibition Increases 4-Repeat Isoform Tau by SRSF2 Upregulation
2014
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
How to diagnose parkinsonian central pain?
2019
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
Expression of Concern: Glycogen synthase kinase 3β (GSK3β) mediates 6‐ hydroxydopamine‐induced neuronal death
2004
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Preceding pain symptoms and P arkinson's disease: a nationwide population‐based cohort study
2013
Therapeutic prospects for Parkinson disease
2013
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
Diagnosis and Treatment of Parkinson Disease
2020 Standout
2016
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Multiple Sclerosis
2018 Standout
Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes
2004
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Hydrogel bioelectronics
2018 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
The role of small intestinal bacterial overgrowth in Parkinson's disease
2013
Trophic Factor Gene Therapy for Parkinson's Disease
2013
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients
2011
The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities
2020
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
Microbiome–microglia connections via the gut–brain axis
2018
Physiology of Microglia
2011 Standout
Diffusion tensor imaging in parkinsonian syndromes
2013
Works of Karla Eggert being referenced
A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease
2016
Predictors of freezing in Parkinson's disease: A survey of 6,620 patients
2007
Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD)
2014
Clinical risk–benefit assessment of dopamine agonists
2008
The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson’s disease
2008
Patients with idiopathic rapid‐eye‐movement sleep behavior disorder show normal gastric motility assessed by the 13C‐octanoate breath test
2011
Real‐time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease
2010
Costs of drug treatment in Parkinson's disease
1998
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
2005
Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing
2007
AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
2011
Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
2008
Signaling Pathways Mediate the Neuroprotective Effects of GDNF
2002
In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: A DTI study using TBSS
2010
Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
2011
Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro
1999
Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
2010
Costs of Parkinson's disease in Eastern Europe: A Czech cohort study
2009
Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson’s disease
2007
Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson’s disease. A National Survey of German neurologists in private practice
2009
Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
2010
Successful Weight Loss in a Self-Taught, Self-Administered Program
1993
Frequency and treatment of depressive symptoms in a Parkinson's disease registry
2008
Safety, Tolerability and Anti-Dyskinetic Efficacy of Dipraglurant, a Novel mGluR5 Negative Allosteric Modulator (NAM) in Parkinson's Disease (PD) Patients with Levodopa-Induced Dyskinesia (LID) (S23.004)
2013
Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)
2017
Pain in Parkinson's Disease: Current Concepts and a New Diagnostic Algorithm
2015
In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear Palsy
2009